|
|
|
Volumn 158 Suppl 3, Issue , 1998, Pages
|
|
Adjuvant systemic therapy for women with node-negative breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
METHOTREXATE;
TAMOXIFEN;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGE;
AGED;
BREAST TUMOR;
CANCER STAGING;
FEMALE;
HUMAN;
MIDDLE AGED;
PRACTICE GUIDELINE;
PROFESSIONAL STANDARD;
PROGNOSIS;
REVIEW;
ADULT;
AGE FACTORS;
AGED;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
FLUOROURACIL;
HUMANS;
METHOTREXATE;
MIDDLE AGED;
NEOPLASM STAGING;
PROFESSIONAL STAFF COMMITTEES;
PROGNOSIS;
TAMOXIFEN;
|
|
EID: 0032501779
PISSN: 08203946
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (38)
|
|
References (68)
|